There are 2789 resources available
Discussion 1508MO, 1509MO and 1510MO_PR
Presenter: Dario Trapani
Session: Mini oral session - Public policy
Resources:
Slides
Webcast
Discussion 654MO, 655MO and 656MO
Presenter: Samra Turajlic
Session: Mini oral session - Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
Discussion 659MO and LBA31
Presenter: Ignacio Duran
Session: Mini oral session - Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
Discussion 657MO and 658MO
Presenter: Sumanta Pal
Session: Mini oral session - Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
Introduction by the chair
Presenter: Florence Joly
Session: Should we test our patients in clinical practice with HRD? How and when?
Resources:
Slides
Webcast
Yes
Presenter: Isabelle Ray-Coquard
Session: Should we test our patients in clinical practice with HRD? How and when?
Resources:
Slides
Webcast
No
Presenter: Antonio Jose Gonzalez Martin
Session: Should we test our patients in clinical practice with HRD? How and when?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Florence Joly
Session: Should we test our patients in clinical practice with HRD? How and when?
Resources:
Slides
Webcast
Q&A
Presenter: Florence Joly
Session: Should we test our patients in clinical practice with HRD? How and when?
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Jens Bedke
Session: ESMO Colloquium supported by Eisai Europe Ltd - How to optimise efficacy and safety of targeted agent/IO management strategies in advanced solid tumours: Single agents, combinations and biomarkers
Resources:
Slides
Webcast